Opposite effects of tamoxifen on metabolic syndrome-induced bladder and prostate alterations: A role for GPR30/GPER?

Tamoxifen for the management of breast events induced by non-steroidal antiandrogens in patients with prostate cancer: a systematic review

(2012) Frank Kunath et al.   BMC Medicine

Testosterone treatment improves metabolic syndrome-induced adipose tissue derangements

(2012) Elena Maneschi et al.   JOURNAL OF ENDOCRINOLOGY

Antiinflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells

(2012) Linda Vignozzi et al.   JOURNAL OF ENDOCRINOLOGY

Testosterone/Estradiol Ratio Regulates NO‐Induced Bladder Relaxation and Responsiveness to PDE5 Inhibitors

(2012) Linda Vignozzi et al.   Journal of Sexual Medicine

Testosterone and farnesoid X receptor agonist INT-747 counteract high fat diet-induced bladder alterations in a rabbit model of metabolic syndrome

(2012) Annamaria Morelli et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Fat boosts, while androgen receptor activation counteracts, BPH-associated prostate inflammation

(2012) Linda Vignozzi et al.   PROSTATE

Mechanism of action of phosphodiesterase type 5 inhibition in metabolic syndrome-associated prostate alterations: An experimental study in the rabbit

(2012) Annamaria Morelli et al.   PROSTATE

Metabolic syndrome and lower urinary tract symptoms: the role of inflammation

(2012) M Gacci et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Associations Between Longitudinal Changes in Serum Estrogen, Testosterone, and Bioavailable Testosterone and Changes in Benign Urologic Outcomes

(2011) J. L. St. Sauver et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Testosterone Deficiency

(2011) Abdulmaged M. Traish et al.   AMERICAN JOURNAL OF MEDICINE

Testosterone, cardiovascular disease and the metabolic syndrome

(2011) Giovanni Corona et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Androgens and estrogens in benign prostatic hyperplasia: Past, present and future

(2011) Tristan M. Nicholson et al.   DIFFERENTIATION

Testosterone protects from metabolic syndrome-associated prostate inflammation: an experimental study in rabbit

(2011) Linda Vignozzi et al.   JOURNAL OF ENDOCRINOLOGY

Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: Pathophysiology and mechanism(s) of action

(2011) Karl-Erik Andersson et al.   NEUROUROLOGY AND URODYNAMICS

Androgen replacement therapy contributes to improving lower urinary tract symptoms in patients with hypogonadism and benign prostate hypertrophy: a randomised controlled study

(2010) Kazuyoshi Shigehara et al.   Aging Male

Testosterone replacement therapy by testosterone ointment relieves lower urinary tract symptoms in late onset hypogonadism patients

(2010) Toshiyasu Amano et al.   Aging Male

Estrogen Receptors: Therapies Targeted to Receptor Subtypes

(2010) S Nilsson et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Benign prostate hyperplasia: a review of the yearʼs progress from bench to clinic

(2010) Robert F Donnell   CURRENT OPINION IN UROLOGY

Lifestyle factors, benign prostatic hyperplasia, and lower urinary tract symptoms

(2010) JK Parsons   CURRENT OPINION IN UROLOGY

Sex Steroid Receptors in Male Human Bladder: Expression and Biological Function

(2010) Aravinda K. Chavalmane et al.   Journal of Sexual Medicine

Farnesoid X Receptor Activation Improves Erectile Function in Animal Models of Metabolic Syndrome and Diabetes

(2010) Linda Vignozzi et al.   Journal of Sexual Medicine

Testosterone and Metabolic Syndrome: A Meta‐Analysis Study

(2010) Giovanni Corona et al.   Journal of Sexual Medicine

Prevalence and factors associated with uncomplicated storage and voiding lower urinary tract symptoms in community-dwelling Australian men

(2010) Sean A. Martin et al.   WORLD JOURNAL OF UROLOGY

Concurrent improvement of the metabolic syndrome and lower urinary tract symptoms upon normalisation of plasma testosterone levels in hypogonadal elderly men

(2009) A. Haider et al.   ANDROLOGIA

Serum sex hormones and the 20-year risk of lower urinary tract symptoms in community-dwelling older men

(2009) Michael D. Trifiro et al.   BJU INTERNATIONAL

Lower urinary tract symptoms, obesity and the metabolic syndrome

(2009) Samdeep Moul et al.   CURRENT OPINION IN UROLOGY

Hypogonadism, ED, metabolic syndrome and obesity: a pathological link supporting cardiovascular diseases

(2009) G. Corona et al.   INTERNATIONAL JOURNAL OF ANDROLOGY

Chronic inflammation in the pathogenesis of benign prostatic hyperplasia

(2009) B. Fibbi et al.   INTERNATIONAL JOURNAL OF ANDROLOGY

Lower urinary tract symptoms in relation to lifestyle and medical conditions in Japanese workers

(2009) Kentaro Tomita et al.   INTERNATIONAL JOURNAL OF UROLOGY

Testosterone Partially Ameliorates Metabolic Profile and Erectile Responsiveness to PDE5 Inhibitors in an Animal Model of Male Metabolic Syndrome

(2009) Sandra Filippi et al.   Journal of Sexual Medicine

Vardenafil Modulates Bladder Contractility Through cGMP-mediated Inhibition of RhoA/Rho Kinase Signaling Pathway in Spontaneously Hypertensive Rats

(2009) Annamaria Morelli et al.   Journal of Sexual Medicine

Acute Vardenafil Administration Improves Bladder Oxygenation in Spontaneously Hypertensive Rats

(2009) Annamaria Morelli et al.   Journal of Sexual Medicine

Characterization of Phosphodiesterase Type 5 Expression and Functional Activity in the Human Male Lower Urinary Tract

(2009) Benedetta Fibbi et al.   Journal of Sexual Medicine

Testosterone deficiency, insulin resistance and the metabolic syndrome

(2009) Michael Zitzmann   Nature Reviews Endocrinology

Lower urinary tract symptoms, benign prostatic hyperplasia, and obesity

(2009) Anne K. Mongiu et al.   Current Urology Reports

Beneficial effects of testosterone administration on symptoms of the lower urinary tract in men with late-onset hypogonadism: A pilot study

(2008) S. Kalinchenko et al.   Aging Male

Lower urinary tract symptoms and its potential relation with late-onset hypogonadism

(2008) Wisuit Pradidarcheep   Aging Male

The effect of testosterone therapy on lower urinary tract symptoms/bladder and sexual functions in men with symptomatic late-onset hypogonadism

(2008) Sinan KarazindiyanoĞlu et al.   Aging Male

Serum Steroid and Sex Hormone-Binding Globulin Concentrations and the Risk of Incident Benign Prostatic Hyperplasia: Results From the Prostate Cancer Prevention Trial

(2008) A. R. Kristal et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Development of Diabesity in Mice with Neuronal Deletion of Shp2 Tyrosine Phosphatase

(2008) Maryla Krajewska et al.   AMERICAN JOURNAL OF PATHOLOGY

Estrogen Signaling through the Transmembrane G Protein–Coupled Receptor GPR30

(2008) Eric R. Prossnitz et al.   Annual Review of Physiology

Impact of androgen/estrogen ratio: Lessons learned from the aromatase over-expression mice

(2008) Xiangdong Li et al.   GENERAL AND COMPARATIVE ENDOCRINOLOGY

Oestrogen and benign prostatic hyperplasia: effects on stromal cell proliferation and local formation from androgen

(2008) Clement K M Ho et al.   JOURNAL OF ENDOCRINOLOGY

Birth Weight, Abdominal Obesity and the Risk of Lower Urinary Tract Symptoms in a Population Based Study of Swedish Men

(2008) Brett A. Laven et al.   JOURNAL OF UROLOGY

The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF-kB pathways

(2008) Giuseppe Penna et al.   PROSTATE

Insulin and free oestradiol are independent risk factors for benign prostatic hyperplasia

(2008) J Hammarsten et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Association Between Lower Urinary Tract Symptoms and Serum Levels of Sex Hormones in Men

(2008) Yoshiji Miwa et al.   UROLOGY